Company intelligence / Profile preview

Arrowhead Wellness

Pasadena, California, United States

Ownership: Private
Employees: ~450
Development stage: Other

Overview

Arrowhead Pharmaceuticals has a broad pipeline of RNA interference-based therapeutics targeting cardiometabolic, liver, pulmonary, and rare diseases. Several programs are in mid-to-late clinical development with major partnerships established for commercialization. Notable results include successful advancement of candidates into pivotal trials and large licensing deals with Amgen and Janssen for cardiovascular and hepatitis B therapies respectively.

Therapeutic areas: Metabolic DisordersNeurologyPulmonologyInfectious DiseasesGastroenterologyCardiovascular
Modalities: Small interfering RNARNA therapy
Industry: Biotech

Partnerships

AmgenGSKJanssen/J&JTakeda

Beyond the preview

Go deeper on Arrowhead Wellness.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arrowhead Wellness.

Explore the full profile